Novavax begins delivery of its long-delayed COVID-19 vaccine in Europenews2022-02-23T16:14:11+00:00February 23rd, 2022|Fierce Pharma|
Gearing up for anemia market-grab against GSK—and maybe AZ—Akebia expands Vifor pact with $85M for key launchnews2022-02-23T15:42:32+00:00February 23rd, 2022|Fierce Pharma|
Intellia leases new facility to produce CRISPR-based therapiesnews2022-02-23T15:40:58+00:00February 23rd, 2022|Fierce Pharma|
Johnson & Johnson, Moderna set to face shareholder votes on vaccine pricing strategy, manufacturing tech sharingnews2022-02-23T15:27:03+00:00February 23rd, 2022|Fierce Pharma|
UPDATED: J&J, Pfizer and Moderna set to face shareholder votes on vaccine pricing strategy, manufacturing tech sharingnews2022-02-23T15:27:03+00:00February 23rd, 2022|Fierce Pharma|
UPDATED: Pfizer to join J&J, Moderna in shareholder vote showdown on vaccine pricing strategy, manufacturing tech sharingnews2022-02-23T15:27:03+00:00February 23rd, 2022|Fierce Pharma|
Mallinckrodt blames manufacturing issue for FDA rejection of its rare kidney disorder mednews2022-02-23T14:45:32+00:00February 23rd, 2022|Fierce Pharma|
AbbVie advances major depressive disorder ambitions for Vraylar with hopes for $4B-plus in salesnews2022-02-23T14:30:43+00:00February 23rd, 2022|Fierce Pharma|
Moderna taps Thermo Fisher for 15-year mRNA production pact for COVID vaccines and morenews2022-02-23T13:37:10+00:00February 23rd, 2022|Fierce Pharma|
What do patients really think about their meds? A new AI bot can tell younews2022-02-23T12:51:37+00:00February 23rd, 2022|Fierce Pharma|
